Y Fujiwara Selected Research

Y Fujiwara Research Topics

Disease

37	Neoplasms (Cancer) 04/2024 - 01/2000
12	Neoplasm Micrometastasis 10/2001 - 03/2000
11	Breast Neoplasms (Breast Cancer) 01/2017 - 05/2000
9	Carcinoma (Carcinomatosis) 12/2016 - 04/2000
9	Ulcer 02/2007 - 01/2000
8	Stomach Neoplasms (Stomach Cancer) 05/2008 - 01/2000
8	Esophageal Neoplasms (Esophageal Cancer) 01/2008 - 01/2000
8	Stomach Ulcer (Gastric Ulcer) 02/2007 - 01/2000
7	Neoplasm Metastasis (Metastasis) 01/2016 - 12/2000
6	Lung Neoplasms (Lung Cancer) 02/2011 - 04/2000
6	Colorectal Neoplasms (Colorectal Cancer) 10/2010 - 02/2000
6	Infections 08/2009 - 01/2000
6	Gastroesophageal Reflux (GERD) 07/2007 - 01/2000
5	Body Weight (Weight, Body) 01/2018 - 01/2000
5	Lymphatic Metastasis 01/2016 - 01/2001
5	Carcinogenesis 12/2001 - 03/2000
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2001 - 01/2000
5	Hepatocellular Carcinoma (Hepatoma) 03/2001 - 03/2000
4	Disease Progression 12/2016 - 06/2001
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2016 - 02/2001
4	Type 2 Diabetes Mellitus (MODY) 06/2016 - 04/2000
4	Cicatrix (Scar) 06/2012 - 06/2001
4	Colonic Neoplasms (Colon Cancer) 07/2004 - 03/2000
4	Melanoma (Melanoma, Malignant) 08/2001 - 04/2000
3	Frailty 01/2021 - 01/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 03/2000
3	Heartburn (Pyrosis) 04/2016 - 08/2003
3	Esophageal Squamous Cell Carcinoma 02/2012 - 01/2000
3	Necrosis 02/2008 - 06/2001
3	Hemorrhage 11/2007 - 04/2000
3	Hyperplasia 04/2006 - 12/2001
3	Adenocarcinoma 09/2001 - 03/2000
2	Deglutition Disorders (Dysphagia) 10/2017 - 06/2012
2	Pathologic Complete Response 08/2016 - 07/2010
2	Eosinophilia 05/2015 - 04/2015
2	Pathologic Constriction (Stenosis) 06/2012 - 02/2001
2	Inflammation (Inflammations) 05/2008 - 01/2001
2	Gastritis 01/2004 - 07/2003
2	Schizophrenia (Dementia Praecox) 01/2002 - 08/2000
2	Peptic Esophagitis (Reflux Esophagitis) 12/2001 - 01/2000
2	Pneumoperitoneum 10/2001 - 01/2000
2	Obstructive Jaundice (Cholestatic Jaundice) 02/2001 - 01/2000

Drug/Important Bio-Agent (IBA)

14	Messenger RNA (mRNA)IBA 12/2001 - 01/2000
9	AcidsIBA 07/2007 - 06/2001
7	Carcinoembryonic AntigenIBA 01/2016 - 02/2000
7	Proteins (Proteins, Gene)FDA Link 05/2008 - 01/2000
6	Proton Pump InhibitorsIBA 04/2016 - 01/2003
6	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2001 - 03/2000
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2009
4	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2000
4	CytokinesIBA 05/2008 - 01/2001
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2008 - 01/2000
3	Carboplatin (JM8)FDA LinkGeneric 12/2016 - 04/2000
3	Trastuzumab (Herceptin)FDA Link 06/2011 - 11/2009
3	Famotidine (Pepcid)FDA LinkGeneric 12/2006 - 01/2005
3	Phosphotransferases (Kinase)IBA 07/2004 - 04/2001
3	Peroxidase (Myeloperoxidase)IBA 07/2003 - 01/2000
3	Mammaglobin BIBA 06/2000 - 03/2000
2	Cystatin CIBA 01/2023 - 01/2022
2	Serum AlbuminIBA 01/2022 - 01/2018
2	Gemcitabine FDA Link 01/2021 - 04/2017
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 12/2000
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2009
2	Docetaxel (Taxotere)FDA Link 12/2016 - 07/2001
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 06/2012 - 08/2001
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2012 - 07/2004
2	AnticoagulantsIBA 10/2010 - 11/2000
2	SteroidsIBA 08/2009 - 02/2001
2	Rabeprazole (Aciphex)FDA Link 05/2008 - 07/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2008 - 01/2003
2	LigandsIBA 02/2008 - 09/2001
2	Therapeutic UsesIBA 01/2008 - 03/2001
2	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 06/2007 - 07/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2006 - 04/2000
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2004 - 01/2000
2	Clarithromycin (Biaxin)FDA LinkGeneric 01/2003 - 10/2001
2	heparanaseIBA 12/2001 - 10/2001
2	EnzymesIBA 10/2001 - 04/2000
2	Cell-Free Nucleic AcidsIBA 08/2001 - 04/2000
2	Genetic Markers (Genetic Marker)IBA 08/2001 - 05/2001
2	enhanced green fluorescent proteinIBA 07/2001 - 05/2000
2	Green Fluorescent ProteinsIBA 07/2001 - 05/2000
2	Cell Adhesion MoleculesIBA 06/2001 - 05/2000
2	Estrogen ReceptorsIBA 05/2001 - 11/2000
2	Keratin-20 (Cytokeratin 20)IBA 05/2001 - 07/2000
2	CholesterolIBA 03/2001 - 09/2000

Therapy/Procedure

22	Therapeutics 04/2024 - 01/2000
14	Drug Therapy (Chemotherapy) 01/2021 - 12/2000
8	Lymph Node Excision (Lymph Node Dissection) 05/2015 - 01/2001
7	Neoadjuvant Therapy 01/2021 - 05/2008
5	Radiotherapy 04/2017 - 12/2000
5	Gastrectomy 05/2008 - 01/2000
5	Esophagectomy 01/2008 - 01/2000
4	Ligation 04/2002 - 01/2000
3	Aftercare (After-Treatment) 01/2008 - 03/2001
3	Hepatectomy 03/2001 - 04/2000
2	Intraperitoneal Injections 01/2008 - 01/2000
2	Operative Surgical Procedures 08/2003 - 01/2000
2	Surgical Instruments (Clip) 03/2003 - 11/2002
2	Anesthesia 12/2001 - 01/2000